Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Nuclear Medicine Market, by Product Type
6.1 Introduction
6.2 Diagnostic Nuclear Medicine
6.2.1 SPECT Radiopharmaceuticals
6.2.1.1 Tc-99m
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.1.2 TI-201
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.1.3 Ga-67
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.1.4 I-123
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.1.1.5 Others
6.2.2 Pet Radiopharmaceuticals
6.2.2.1 F-18
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2.2 Ru-82
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2.3 Others
6.3 Therapeutic Nuclear Medicine
6.3.1 Alpha Emitters
6.3.1.1 Ra-223
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2 Beta Emitters
6.3.2.1 I-131
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2.2 Y-90
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2.3 Sm-153
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2.4 Lu-177
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2.5 Re-186
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2.6 Others
6.3.3 Brachytherapy Isoptopes
6.3.3.1 Ir-192
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.3.2 I-125
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.3.3 Pd-103
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.3.4 Cs-131
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.3.5 Others
Chapter 7. Global Nuclear Medicine Market, by Application
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 SPECT Applications
7.2.1.1 Cardiology
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.1.2 Neurology
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.1.3 Lymphoma
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.1.4 Thyroid
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.1.5 Others
7.2.2 PECT Applications
7.2.2.1 Oncology
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.2.2 Cardiology
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.2.3 Neurology
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.2.4 Others
7.3 Therapeutic Applications
7.3.1 Thyriod
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.2 Bone Metastasis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.3 Endrocrine Tumors
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.4 Lymphoma
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.5 Others
Chapter 8. Global Nuclear Medicine Market, by End User
8.1 Introduction
8.2 Hospitals and Diagnostic Centers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3 Research Institutes
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.4 Others
Chapter 9. Global Nuclear Medicine Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Cardinal Health
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 GE Healthcare
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bayer AG
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Bracco Imaging
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Curium
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Lantheus Medical Imaging
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Nordion, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Advanced Accelerators Applications
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Mallinckrodt Pharmaceuticals
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Jubliant Lifesciences
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Medtronic plc
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Nuclear Medicine Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Nuclear Medicine Market Synopsis, 2020–2027
Table 2 Global Nuclear Medicine Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Nuclear Medicine Market by Region, 2020–2027 (USD Million)
Table 4 Global Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 5 Global Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 6 Global Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 7 North America: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 8 North America: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 9 North America: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 10 US: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 11 US: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 12 US: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 13 Canada: Nuclear Medicine Market,by Product Type, 2020–2027 (USD Million)
Table 14 Canada: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 15 Canada: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 16 South America: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 17 South America: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 18 South America: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 19 Europe: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 20 Europe: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 21 Europe: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 22 Western Europe: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 23 Western Europe: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 24 Western Europe: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 25 Eastern Europe: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 26 Eastern Europe: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 27 Eastern Europe: Nuclear Medicine Market by End User, 2020–2027(USD Million)
Table 28 Asia-Pacific: Nuclear Medicine Market by Product Type, 2020–2027 (USD Million)
Table 29 Asia-Pacific: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 30 Asia-Pacific: Nuclear Medicine Market by End User, 2020–2027 (USD Million)
Table 31 Middle East & Africa: Nuclear Medicine Market by Product Type, 2020–2027(USD Million)
Table 32 Middle East & Africa: Nuclear Medicine Market by Application, 2020–2027 (USD Million)
Table 33 Middle East & Africa: Nuclear Medicine Market by End User,2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Nuclear Medicine Market
Figure 3 Segmentation Market Dynamics for Global Nuclear Medicine Market
Figure 4 Global Nuclear Medicine Market Share, by Product Type, 2020
Figure 5 Global Nuclear Medicine Market Share, by Application, 2020
Figure 6 Global Nuclear Medicine Market Share, by End User, 2020
Figure 7 Global Nuclear Medicine Marke tShare, by Region, 2020
Figure 8 North America: Nuclear Medicine Market Share, by Country, 2020
Figure 9 Europe: Nuclear Medicine Market Share, by Country, 2020
Figure 10 Asia-Pacific: Nuclear Medicine Market Share, by Country, 2020
Figure 11 Middle East & Africa: Nuclear Medicine Market Share, by Country, 2020
Figure 12 Global Nuclear Medicine Market: Company Share Analysis, 2020 (%)
Figure 13 Cardinal Health: Key Financials
Figure 14 Cardinal Health: Segmental Revenue
Figure 15 Cardinal Health: Geographical Revenue
Figure 16 GE Healthcare: Key Financials
Figure 17 GE Healthcare: Segmental Revenue
Figure 18 GE Healthcare: Geographical Revenue
Figure 19 Bayer AG: Key Financials
Figure 20 Bayer AG: Segmental Revenue
Figure 21 Bayer AG: Geographical Revenue
Figure 22 Bracco Imaging : Key Financials
Figure 23 Bracco Imaging: Segmental Revenue
Figure 24 Bracco Imaging : Geographical Revenue
Figure 25 Curium: Key Financials
Figure 26 Curium: Segmental Revenue
Figure 27 Curium. Geographical Revenue
Figure 28 Lantheus Medical Imaging: Key Financials
Figure 29 Lantheus Medical Imaging: Segmental Revenue
Figure 30 Lantheus Medical Imaging: Geographical Revenue
Figure 31 Nordion, Inc.: Key Financials
Figure 32 Nordion, Inc.: Segmental Revenue
Figure 33 Nordion, Inc.: Geographical Revenue
Figure 34 Advanced Accelerators Applications: Key Financials
Figure 35 Advanced Accelerators Applications: Segmental Revenue
Figure 36 Advanced Accelerators Applications: Geographical Revenue
Figure 37 Mallinckrodt Pharmaceuticals: Key Financials
Figure 38 Mallinckrodt Pharmaceuticals: Segmental Revenue
Figure 39 Mallinckrodt Pharmaceuticals: Geographical Revenue
Figure 40 Jubliant Lifesciences: Key Financials
Figure 41 Jubliant Lifesciences: Segmental Revenue
Figure 42 Jubliant Lifesciences: Geographical Revenue
Figure 43 Medtronic plc: Key Financials
Figure 44 Medtronic plc: Segmental Revenue
Figure 45 Medtronic plc: Geographical Revenue
